ni2o

Mclean, United States Founded: 2017 • Age: 9 yrs
AI-driven brain-computer interface chip

About ni2o

ni2o is a company based in Mclean (United States) founded in 2017.. ni2o offers products and services including KIWI and ni2o RapidTest. ni2o operates in a competitive market with competitors including PhotoPharmics, Cala Health, Civitas Therapeutics, Sapiens Neuro and Kinetikos Health, among others.

  • Headquarter Mclean, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $750 K (USD), Debt – Conventional

    May 18, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ni2o

ni2o offers a comprehensive portfolio of products and services, including KIWI and ni2o RapidTest. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Minimally invasive implant for Parkinson's disease treatment

Rapid testing system for neurological conditions

People of ni2o
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 5
Employee Profiles
People
Newton Howard
CEO
People
Richard Wirt
Chief Technology Officer
People
Karthik Kaundinya
Program Engineer
People
Rebecca Howard
Director of Research

Unlock access to complete

Board Members and Advisors
people
John Stein
Advisor
people
Tipu Aziz
Advisor
people
Ricky Caplin
Advisor

Unlock access to complete

Funding Insights of ni2o

  • Total Funding
  • Total Rounds 2
  • Last Round Debt – Conventional — $750,000
  • First Round

    (27 Apr 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Debt – Conventional - ni2o Valuation

investors

Apr, 2021 Amount Debt – Conventional - ni2o Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by ni2o

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ni2o

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ni2o Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ni2o

ni2o operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Cala Health, Civitas Therapeutics, Sapiens Neuro and Kinetikos Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-invasive phototherapy for Parkinson's disease is developed.
domain founded_year HQ Location
Wearable neuromodulation devices for essential tremor relief are developed.
domain founded_year HQ Location
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
domain founded_year HQ Location
Developer of brain stimulation device to treat neurodegenerative disorders
domain founded_year HQ Location
Digital platform to assist healthcare providers and patients in the management of Parkinson’s disease
domain founded_year HQ Location
Non-invasive wearable devices for Parkinson's management are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ni2o

Frequently Asked Questions about ni2o

When was ni2o founded?

ni2o was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is ni2o located?

ni2o is headquartered in Mclean, United States. It is registered at Mclean, Virginia, United States.

Who is the current CEO of ni2o?

Russ Hayward is the current CEO of ni2o.

What does ni2o do?

NI2O is developing an AI-driven brain-computer interface. The company is developing Kiwi, a chip (size of rice grain) which can be implanted in the brain via the nasal cavity. The chip interacts with neurons using light and electrical impulses and will be used to treat neurological disorders, degenerative diseases, and cognitive enhancement. The company is in the stealth mode and looking for investors and partners as of June 2018.

Who are the top competitors of ni2o?

ni2o's top competitors include PhotoPharmics, Cala Health and Aleva Neuro.

What products or services does ni2o offer?

ni2o offers KIWI and ni2o RapidTest.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available